TrialFrontiers in pharmacology2026

Yangyin Fuzheng Jiedu prescription as an adjunct to minimally invasive treatment in early-stage hepatocellular carcinoma: a randomized controlled trial.

Huiwen Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.